QQ客服 官方微博 反馈留言

	The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
	Lan Jiaming; Yao Yanfeng; Yao, Deng; Hu Yawei; Bao Linlin; Huang Baoying; Yan Jinghua; Gao, George F.; Chuan, Qin; Tan Wenjie
	2017
卷号	35期号:1页码:10-18
关键词	MERS-CoV Vaccine Mice NTD RBD Animal model
ISSN号	0264-410X
DOI	10.1016/j.vaccine.2016.11.064
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6362651
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Lan Jiaming,Yao Yanfeng,Yao, Deng,et al. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection[J],2017,35(1):10-18.
APA	Lan Jiaming.,Yao Yanfeng.,Yao, Deng.,Hu Yawei.,Bao Linlin.,...&Tan Wenjie.(2017).The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.,35(1),10-18.
MLA	Lan Jiaming,et al."The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection".35.1(2017):10-18.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。